Mirae Asset Global Investments’s Treace Medical Concepts TMCI Stock Holding History

Mirae Asset Global Investments’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16,277	Closed	-$408K	–	2459
2024 Q1	$408K	Sell	16,277 -4,448	-21%	-$59.3K	﹤0.01%	1990
2023 Q4	$264K	Hold	20,725	–	–	﹤0.01%	2246
2023 Q3	$272K	Hold	20,725	–	–	﹤0.01%	2173
2023 Q2	$530K	Buy	20,725 +4,448	+27%	+$115K	﹤0.01%	1924
2023 Q1	$410K	Buy	16,277 +2,300	+16%	+$54K	﹤0.01%	2024
2022 Q4	$321K	Hold	13,977	–	–	﹤0.01%	2123
2022 Q3	$308K	Buy	+13,977	New	+$270K	﹤0.01%	2144

Other funds holding TMCI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Mirae Asset Global Investments's TMCI Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Treace Medical Concepts (TMCI) in Q2 2024, closing a stake of 16,277 shares — an estimated $408K sold.

Mirae Asset Global Investments first reported a position in TMCI in Q3 2022 and held it in 7 quarters. The position peaked at $530K in Q2 2023. 128 funds tracked by Wall St. Rank hold TMCI as of Q2 2024.

Mirae Asset Global Investments reported no remaining Treace Medical Concepts position as of Q2 2024 after selling out during the quarter.
Mirae Asset Global Investments sold 16,277 Treace Medical Concepts shares in Q2 2024, an estimated $408K.
Mirae Asset Global Investments first reported a position in Treace Medical Concepts in Q3 2022 and held it in 7 quarters.
Mirae Asset Global Investments's Treace Medical Concepts position peaked at $530K in Q2 2023.
128 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.